Skip to main content
. 2015 May 6;55(9):985–994. doi: 10.1002/jcph.502

Table 1.

Patient Characteristics (Safety Population, N = 32)

Demographic or Baseline Characteristic StaccatoPlacebo (N = 8) StaccatoLoxapine 15 mg (N = 8) StaccatoLoxapine 20 mg (N = 8) StaccatoLoxapine 30 mg (N = 8) Overall Study Population (N = 32)
Sex, n (%):
Female 3 (37.5%) 2 (25.0%) 3 (37.5%) 2 (25.0%) 10 (31.3%)
Male 5 (62.5%)a 6 (75.0%) 5 (62.5%) 6 (75.0%) 22 (68.8%)
Age (years)
Mean (SD) 40.4 (10.8) 42.5 (7.7) 44.3 (8.1) 50.9 (11.3) 44.5 (10.0)
Median 40.5 43.5 45.0 53.0 44.5
Min, max 24, 56 27, 52 33, 56 34, 65 24, 65
Height (cm)
Mean (SD) 169 (5.6) 164 (15.2) 173 (6.7) 175 (9.0) 170 (10.2)
Median 169 165 173 175 170
Min, max 160, 175 137, 183 165, 183 163, 185 137, 185
Weight (kg)
Mean (SD) 79.0 (12.8) 91.2 (13.8) 82.6 (13.2) 89.4 (17.2) 85.6 (14.6)
Median 74.6 95.1 80.3 92.9 86.8
Min, max 63.5, 95.5 63.0, 106 62.5, 104 61.4, 111 61.4, 111
Race, n (%)
Caucasian 0 0 1 (12.5%) 0 1 (3.1%)
Black 8 (100%) 7 (87.5%) 7 (87.5%) 8 (100%) 30 (93.8%)
Hispanic 0 0 0 0 0
Asian 0 0 0 0 0
Native American 0 1 (12.5%) 0 0 1 (3.1%)
Smoking history, n (%)
Current smoker 7 (87.5%) 7 (87.5%) 7 (87.5%) 7 (87.5%) 28 (87.5%)